ArticleBreast cancer (Dove Medical Press)2015

Pathological response rate in hormone-positive breast cancer patients treated with neoadjuvant FEC and triweekly docetaxel: a case series.

Takayoshi Kiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.